HomeInsightsPE

Remus Pharmaceuticals Ltd PE Ratio

Remus Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 2.7 Cr

Volume transacted

stocks purchased

11.4 K

stocks traded

Last Updated time: 20 Sep 9.00 AM

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PE

69.8

Last updated: 19 Sep 24

Key Highlights

  • The P/E Ratio of Remus Pharmaceuticals Ltd is 69.8 as of 19 Sep 24.
  • The P/E Ratio of Remus Pharmaceuticals Ltd is 47.2 as of March 2024.
  • The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 2410 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.7. In 2024.
Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PE

47.2

Last updated: March 2024

Company Fundamentals for Remus Pharmaceuticals Ltd

No data available

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PRICE

2410.9

32.85 (1.38%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20242410.9
18 Sep 20242378.05
17 Sep 20242424.5
16 Sep 20242472.65
13 Sep 20242555
12 Sep 20242530
11 Sep 20242509.3
10 Sep 20242538.5
09 Sep 20242527.7
06 Sep 20242567.1

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Key Valuation Metric of Remus Pharmaceuticals Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Remus Pharmaceuticals Ltd

No data available

* All values are in %

About Remus Pharmaceuticals Ltd

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
  • Subsequently, Company converted from a private company to public company and consequently, the name of Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad.
  • The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Remus Pharmaceuticals Ltd News Hub

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 202415:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 202412:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 202410:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 202415:16

News

Remus Pharmaceuticals to consider Dividend

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 A...

Read more

17 Apr 202409:39

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

20 Oct 202316:09

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*